Company / Operating Margin
OCULAR THERAPEUTIX, INC Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-519.8%
FY2025
5-year range
-2029.9% / -141.0%
FY2021-FY2025
Trend
-92.8%
vs FY2024
Sector context
#113 of 135
Health Care
What the data says
OCULAR THERAPEUTIX, INC's operating margin of -519.8% is lower than 84% of companies in the Health Care sector (FY2025). Operating Margin has fluctuated over the past 10 years, ranging from -3220.1% in FY2019 to -141.0% in FY2023.
Based on SEC 10-K filings.
-519.8% in FY2025 with a 5-year CAGR of +1510.1%.
Declined from -141.0% to -519.8% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- -158.6pp
- 5-Year Change
- +1510.1pp
- 10-Year Change
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 135This company -519.8% Sector average -774.4%
▼
+32.9% above sector average
Key checks
Key Insights
- In FY2025, operating margin decreased 92.8% year-over-year.
- Currently 254.7pp above the Health Care sector average.
- Peak operating margin was recorded in FY2023.
- Lowest operating margin in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.25 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -519.8% | -92.8% |
| FY2024 | -269.6% | -91.2% |
| FY2023 | -141.0% | +61.0% |
| FY2022 | -361.1% | +82.2% |
| FY2021 | -2029.9% | +0.0% |
| FY2020 | -2029.9% | +37.0% |
| FY2019 | -3220.1% | -8.4% |
| FY2018 | -2970.8% | +7.7% |
| FY2017 | -3220.1% | -40.2% |
| FY2016 | -2296.0% | -37.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026